Evidence map›Paper›PMID 35719866›Full record

ArticleJTO clinical and research reports2022

Automating Access to Real-World Evidence.

Marie-Pier Gauthier, Jennifer H Law, Lisa W Le, Janice J N Li, Sajda Zahir, Sharon Nirmalakumar, Mike Sung, Christopher Pettengell, Steven Aviv, Ryan Chu and 5 more

Open access · goldAbstract read
In one paragraph

Article in JTO clinical and research reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. AI-based augmentation of oncology clinical trials.Nature reviews. Clinical oncology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. A cohort description and comparison of four European national diabetes registries for the REDDIE project.Diabetic medicine : a journal of the British Diabetic Association · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Marie-Pier GauthierDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Jennifer H LawDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Lisa W LeDepartment of Biostatistics, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Janice J N LiDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Sajda ZahirDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Sharon NirmalakumarDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Mike SungDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Christopher PettengellPentavere Research Group Inc., Toronto, Ontario, Canada.
Steven AvivPentavere Research Group Inc., Toronto, Ontario, Canada.
Ryan ChuDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Adrian SacherDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Geoffrey LiuDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Penelope BradburyDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Frances A ShepherdDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Natasha B LeighlDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Princess Margaret Cancer Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Real-world evidence is important in regulatory and funding decisions. Manual data extraction from electronic health records (EHRs) is time-consuming and challenging to maintain. Automated extraction using natural language processing (NLP) and artificial intelligence may facilitate this process. Whereas NLP offers a faster solution than manual methods of extraction, the validity of extracted data remains in question. The current study compared manual and automated data extraction from the EHR of patients with advanced lung cancer. Methods: Previously, we extracted EHRs from 1209 patients diagnosed with advanced lung cancer (stage IIIB or IV) between January 2015 and December 2017 at Princess Margaret Cancer Centre (Toronto, Canada) using the commercially available artificial intelligence engine, DARWEN (Pentavere, Ontario, Canada). For comparison, 100 of 333 patients that received systemic therapy were randomly selected and clinical data manually extracted by two trained abstractors using the same accepted gold standard feature definitions, including patient, disease characteristics, and treatment data. All cases were re-reviewed by an expert adjudicator. Accuracy and concordance between automated and manual methods are reported. Results: Automated extraction required considerably less time (<1 day) than manual extraction (∼225 person-hr). The collection of demographic data (age, sex, diagnosis) was highly accurate and concordant with both methods (96%-100%). Accuracy (for either extraction approach) and concordance were lower for unstructured data elements in EHR, such as performance status, date of diagnosis, and smoking status (NLP accuracy: 88%-94%; Manual accuracy: 78%-94%; concordance: 71%-82%). Concurrent medications (86%-100%) and comorbid conditions (96%-100%), were reported with high accuracy and concordance. Treatment details were also accurately captured with both methods (84%-100%) and highly concordant (83%-99%). Detection of whether biomarker testing was performed was highly accurate and concordant (96%-98%), although detection of biomarker test results was more variable (accuracy 84%-100%, concordance 84%-99%). Features with syntactic or semantic variation requiring clinical interpretation were extracted with slightly lower accuracy by both NLP and manual review. For example, metastatic sites were more accurately identified through NLP extraction (NLP: 88%-99%; manual: 71%-100%; concordance: 70%-99%) with the exception of lung and lymph node metastases (NLP: 66%-71%; manual: 87%-92%; concordance: 58%) owing to analogous terms used in radiology reports not being included in the accepted gold standard definition. Conclusions: Automated data abstraction from EHR is highly accurate and faster than manual abstraction. Key challenges include poorly structured EHR and the use of analogous terms beyond the accepted gold standard definition. The application of NLP can facilitate real-world evidence studies at a greater scale than could be achieved with manual data extraction.

Indexed as

Artificial intelligenceHealth recordsNatural language processingReal-world dataReal-world evidenceValidation

Identifiers

PMID35719866
PMCPMC9201015
OpenAlexW4280525579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.